BioSpace News Archive

Drug Development

Positive Phase III Results for Genentech’s HEMLIBRA (emicizumab-kxwh) for Hemophilia A Without Factor VIII Inhibitors Published in New England Journal of Medicine

HEMLIBRA prophylaxis significantly reduced bleeds compared to no prophylaxis

August 30, 2018
·
11 min read
Business

Ascletis Appoints Mr. Joshua Zhongbao Ling as VP Finance

Ascletis Pharma Inc. announced today that Mr. Joshua Zhongbao Ling joined Ascletis as Vice President of Finance. Mr. Ling will be responsible for the corporate finance management.

August 30, 2018
·
1 min read
Crop Subsidiary to Open Italian Retail Locations Launching its First Line of Hemp Oil Infused Products in Italy

CROP Infrastructure Corp. announces it will launch its first line of Hemp oil infused cosmetic and therapeutic products under the brand ‘URBAN JUVE’, pursuant to its previously announced License Agreement with The Yield Growth Corp.'s subsidiary, Urban Juve Provisions Inc.

August 30, 2018
·
5 min read
Pharm Country

Schrödinger to Participate in Citi 13th Annual Biotech Conference

Schrödinger, Inc. announced today that the Company will participate in a panel discussion entitled “Emerging Innovators - An Introduction to Biotech Privates” at the Citi 13th Annual Biotech Conference

August 30, 2018
·
1 min read
Business

/R E P E A T -- Notice to the media - The Government of Canada and the Government of Nova Scotia to announce bilateral agreement/

On behalf of the Minister of Health, the Honourable Scott Brison, President of the Treasury Board and the Honourable Randy Delorey, Minister of Health and Wellness for Nova Scotia will sign a bilateral agreement.

August 30, 2018
·
1 min read
Business

WellCare Announces Appearance at Investor Conference on September 13, 2018

WellCare Health Plans, Inc. today announced that members of its management team are scheduled to present at the Morgan Stanley 16th Annual Global Healthcare Conference on September 13, 2018, at approximately 8:35 a.m. EDT.

August 30, 2018
·
1 min read
Business

Otsuka Announces First Collaboration Agreement to Bring the ABILIFY MYCITE® System to the US Market

The ABILIFY MYCITE System, the first drug-device combination product to be approved by FDA to track drug ingestion, will be integrated into Magellan Health’s mental health provider network

August 30, 2018
·
15 min read
Lone Star Bio

Triumvira Presents Data on T Cell Antigen Coupler (TAC) Technology at the 6th Annual Immuno-Oncology Summit

TAC technology shows efficacy, safety, and TAC-T cell persistence in preclinical models of liquid and solid tumors

August 30, 2018
·
3 min read
BioMidwest

“Overdentures: Current Research” Released by the Journal of Prosthodontics

The Latest Scientific Literature on this Widely-Used Treatment, Compiled in One Great Virtual Resource

August 30, 2018
·
2 min read
BioLineRx to Present at 20th Annual Rodman & Renshaw Global Investment Conference in New York

BioLineRx Ltd. today announced that its Chief Executive Officer, Philip Serlin, will present a company update at the 20th Annual Rodman & Renshaw Global Investment Conference

August 30, 2018
·
3 min read